Virtual Diabetes Group Visits Across Health Systems

Running, not enrolling · Not applicable

Conditions studied: T2DM (Type 2 Diabetes Mellitus), Hypertension, Heart Disease Chronic, Stroke, Hyperlipidemias, Peripheral Vascular Diseases, Obesity

In brief

The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).

Key facts

Study ID

NCT06094491

Run by

University of Chicago

People needed

720

Starts

2024-05-03

Expected to finish

2026-06-30

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient at a PARTICIPATING clinic (at least one visit in year prior to first GV)
• Type 2 diabetes
• ≥ 18 years old
• A1C>8% within 6 months prior to first GV (we will first recruit patients with A1C>9%, then if spaces still available A1C>8.5%, then if spaces still available A1C>8%)
• At least one additional cardiovascular condition (hypertension, heart disease, stroke, hyperlipidemia, peripheral vascular disease, or BMI ≥ 30)
• English or Spanish speaking
• PCP assented to recruiting patient
• Patient provides written consent

Where it is running

• Access Community Health Network — Chicago, Illinois, United States
• Advocate Health Care — Orland Park, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.